Literature DB >> 7116316

The prevalence and severity of pain in cancer.

R L Daut, C S Cleeland.   

Abstract

The frequency, severity, and disruptiveness of pain related by 667 cancer patients are reported. The patients, all seen at a comprehensive cancer center, had cancers of the breast, colon and rectum, prostate, or various gynecologic sites. As expected, the proportion of patients with pain varied according to primary site and according to degree of progression of the disease. Pain, when present, was often of at least moderate severity and was felt to interfere with patients' activity and enjoyment of life to a moderate to severe extent. Degree of interference with activity and enjoyment of life was greater when the pain was caused by cancer than when it had another cause. Implications of these findings for professional and lay education and for treatment are discussed.

Entities:  

Mesh:

Year:  1982        PMID: 7116316     DOI: 10.1002/1097-0142(19821101)50:9<1913::aid-cncr2820500944>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  65 in total

1.  Interference with activities due to pain and fatigue: accuracy of ratings across different reporting periods.

Authors:  Joan E Broderick; Stefan Schneider; Joseph E Schwartz; Arthur A Stone
Journal:  Qual Life Res       Date:  2010-06-11       Impact factor: 4.147

Review 2.  The level of association between functional performance status measures and patient-reported outcomes in cancer patients: a systematic review.

Authors:  Thomas M Atkinson; Charissa F Andreotti; Kailey E Roberts; Rebecca M Saracino; Marisol Hernandez; Ethan Basch
Journal:  Support Care Cancer       Date:  2015-08-28       Impact factor: 3.603

Review 3.  Advances in opioid therapy and formulations.

Authors:  Declan Walsh
Journal:  Support Care Cancer       Date:  2004-12-14       Impact factor: 3.603

4.  Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.

Authors:  Darryl T Hamamoto; Subhalakshmi Giridharagopalan; Donald A Simone
Journal:  Eur J Pharmacol       Date:  2006-12-09       Impact factor: 4.432

Review 5.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.

Authors:  Thomas M Atkinson; Tito R Mendoza; Laura Sit; Steven Passik; Howard I Scher; Charles Cleeland; Ethan Basch
Journal:  Pain Med       Date:  2010-01-15       Impact factor: 3.750

7.  Sexual functioning morbidity among cancer survivors. Current status and future research directions.

Authors:  B L Andersen
Journal:  Cancer       Date:  1985-04-15       Impact factor: 6.860

8.  Can End-of-day reports replace momentary assessment of pain and fatigue?

Authors:  Joan E Broderick; Joseph E Schwartz; Stefan Schneider; Arthur A Stone
Journal:  J Pain       Date:  2008-12-13       Impact factor: 5.820

Review 9.  Effectiveness of the World Health Organization cancer pain relief guidelines: an integrative review.

Authors:  Cathy L Carlson
Journal:  J Pain Res       Date:  2016-07-22       Impact factor: 3.133

Review 10.  Management of breakthrough pain in patients with cancer.

Authors:  Leeroy William; Rod Macleod
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.